Mark Fendrick, MD, is Passionate About Colorectal Cancer Screening and Doing it Right
Only about 75% of people with a positive result on a stool-based test for colorectal cancer complete screening with a colonoscopy. Fendrick "won't rest" until it's 90%.
Blood-Based Testing for Colorectal Cancer Screening is Not Quite Ready for Prime Time, Expert Says
Mark Fendrick, MD, thinks that right now, the relative accuracy of blood-based tests for CRC compared with available alternatives is not quite comparable. He explains.
We Need to Shift the Modality Mix for Colorectal Cancer Screening, Says Primary Care Clinician and Researcher Mark Fendrick, MD
With a population goal of having 80% to 90% of age-eligible Americans screened for colorectal cancer, colonoscopy can not be the initial test for everyone, Fendrick emphasizes.
A Novel Look at Colorectal Cancer Screening: Mark Fendrick, MD, Supports a Green Approach
Never considered the carbon footprint left by a screening for colorectal cancer? Fendrick has and did the research to learn more. He explains in this short video.
Stool-Based Testing for Colorectal Cancer Screening is On the Rise: Expert Perspective with Mark Fendrick, MD
The increase in stool-based CRC testing is a logical trend, Hendrick said in an interview, given the convenience plus the 2 million younger adults now eligible for screening.
